Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Antitumor TEPA analogue described by Lithuanian researchers

March 11, 1998

Patient enrollment complete for Gd-Tex phase II trial

March 11, 1998

New melanoma immunotherapy approaches show clinical potential

March 11, 1998

Japanese academics collaborate in the study of oral platinum complex

March 11, 1998

New formulation of methioninase looks promising for clinical testing

March 10, 1998

Troponin I closer to entering clinical trials

March 10, 1998

New antimitotic agent described by Czech investigators

March 10, 1998

Nitrullin evaluated in phase II for melanoma

March 10, 1998

Janssen describes a new cell migration inhibitor

March 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...